Highly functional and prolonged germinal center T follicular helper cell responses are associated with enhanced neutralizing antibody development

Immunity. 2025 Dec 9;58(12):3094-3112.e7. doi: 10.1016/j.immuni.2025.10.008. Epub 2025 Nov 7.

Abstract

Durability of T follicular helper (Tfh) cell responses is pivotal for generating high affinity antibodies. We characterized Tfh cell responses to HIV Env immunization longitudinally in non-human primates, analyzing >500,000 CD4+ T cells from 192 lymph node (LN) samples collected over 60 weeks, including >36,000 vaccine-specific Tfh cells. An escalating-dose priming regimen elicited higher and more sustained Tfh cell responses in LNs, compared with conventional bolus immunization. Multiple vaccine-specific germinal center (GC)-Tfh subpopulations, including interleukin (IL)4hi and IL21hi GC-Tfh cells, were continually present. Antigen-specific Tfh clones persisted within GCs for over 6 months, maintaining stable gene expression profiles and showing no signs of exhaustion. Vaccine-specific Tfh proliferation signatures were detectable for 27+ weeks after priming. Tfh subpopulations correlated with HIV Env-specific antibody and neutralization titers. Additionally, substantial Tfh clonal migration occurred between LNs. Thus, complex populations of GC-Tfh can enhance antibody responses and survive for 48 weeks in GC responses without new antigen delivery, with implications for immunization regimens.

Keywords: AIDS; CD4 T cells; HIV; T follicular helper cells; Tfh; germinal center; germinal center B cells; neutralizing antibodies; single-cell RNA-seq; vaccines.

MeSH terms

  • AIDS Vaccines* / immunology
  • Animals
  • Antibodies, Neutralizing* / immunology
  • Germinal Center* / immunology
  • HIV Antibodies* / immunology
  • HIV Infections* / immunology
  • HIV-1* / immunology
  • Humans
  • Interleukin-21
  • Lymph Nodes / immunology
  • Macaca mulatta
  • T Follicular Helper Cells* / immunology
  • T-Lymphocytes, Helper-Inducer* / immunology
  • env Gene Products, Human Immunodeficiency Virus / immunology

Substances

  • Antibodies, Neutralizing
  • HIV Antibodies
  • AIDS Vaccines
  • env Gene Products, Human Immunodeficiency Virus
  • Interleukin-21